跳至主要内容
临床试验/EUCTR2016-002660-13-ES
EUCTR2016-002660-13-ES进行中(未招募)1 期

Treatment of Ferropenic Anaemia due to acute gastrointestinal bleeding: oral vs intravenous iron therapy

Consorcio Hospital General Universitario de Valencia0 个研究点开始时间: 2016年9月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - 18 year old patients admited in a hospital due to an acute gastrointestinal bleeding, which present a Hb<10 g/dl, once the bleeding has stopped and the patient is stable.
  • - Consent form signed.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 70
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • -Associated disease which can influence the evolution of the anaemia (renal chronic failure, liver disease, inflammatory bowel disease, neoplasia, non controlled thyroid disease, malabsorption, folate deficency and/or cianocobalamine deficiency, epo treatement, HIV and hematic disorder).
  • - Gastrointestinal bleeding during the following (the administration of iron supplement).
  • - Need of blood transfusion during the following (during the administration of iron supplement)
  • - Anaemia of a different origin to ferropenia.
  • - Previous chronic anaemia from any origin.
  • - Contraindication to any drug used in the trial.

研究者

相似试验

已完成
3 期
Evaluation of a single iron infusion versus oral iron tablets in the treatment of pregnancy anaemia among Tasmanian womePregnancy anaemiaPublic Health - Health service researchBlood - AnaemiaReproductive Health and Childbirth - Antenatal care
ACTRN12613000853741aunceston General Hospital156
进行中(未招募)
1 期
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.
EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT
进行中(未招募)
1 期
Treatment of anemia (low red blood cells) with iron infusions in patients listed for a liver transplantatioiron deficiency anemia
EUCTR2017-000703-24-ATMedical University of Vienna; Department of Surgery; Division of Transplantation60
已完成
不适用
Dysregulation of Iron and Ranal Anemia Treatment in patients with chronic kidney diseaseChronic kidney disease
JPRN-UMIN000006833Hyogo College of Medicine250
已完成
4 期
Treatment of iron deficiency anemia with intravenous ferric carboxymaltose versus oral carbonyl iron in patients with cirrhosis
CTRI/2022/11/047650AIIMS New Delhi92